Durham, NC, June 30, 2016 --(PR.com)-- Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that William A. Hawkins and Nicholas Naclerio, PhD have joined the company's Board of Directors effective immediately. Mr. Hawkins is the retired Chairman and CEO of Medtronic, a world-renowned innovative medical technology company. Dr. Naclerio is the Founding Partner of Illumina Ventures, an early stage venture capital firm strategically aligned with Illumina, Inc.
"We are very pleased to welcome both Mr. Hawkins and Dr. Naclerio to our Board and look forward to leveraging their experience as we bring our game-changing product portfolio to market," said Richard West, Baebies' Chief Executive Officer and Co-Founder. "Bill and Nick's proven track records in bringing innovative products to market and their collective global leadership experience make them an excellent addition to our Board."
Mr. Hawkins brings over 30 years of experience in innovative technologies, entrepreneurship, and leading global healthcare ventures to the Baebies' board. Among Mr. Hawkins extensive accomplishments is holding several leadership positions at Medtronic, including serving as Chairman and CEO. Prior to Medtronic, Mr. Hawkins held senior leadership positions at several prominent healthcare companies, such as Johnson & Johnson and Eli Lilly & Co. Most recently, Mr. Hawkins served as President and CEO of Immucor, a provider of transfusion and transplantation diagnostic products worldwide. Mr. Hawkins is active on several public, private and not-for-profit boards and has a consistent track record of shifting healthcare paradigms with innovative solutions.
With his entrepreneurial experience, Dr. Naclerio will propel Baebies' product pipeline and push for more innovative ideas to advance pediatric testing. Dr. Naclerio joined Illumina in 2010 and served as Illumina's Senior Vice President of Corporate and Venture Development through 2016 when he left to found Illumina Ventures in April 2016 as Founding Partner, where he manages investments and participates on company boards. Before joining Illumina, Dr. Naclerio co-founded or served in high profile leadership positions at numerous diagnostic and life science firms, including Quanterix, ParAllele Bioscience, True Materials, and Motorola Life Sciences. Dr. Naclerio has served on a number of corporate and institutional boards.
"I am thrilled to be joining Baebies' Board of Directors," said Bill Hawkins. "The Baebies team has the passion, technology and innovation necessary to rapidly change the landscape of newborn screening and pediatric testing."
About Baebies, Inc.
At Baebies, the sole focus is to advance newborn screening and other pediatric testing worldwide. Baebies is guided by the vision that "everyone deserves a healthy start." Baebies is developing innovative, easy to use and connected products to make life better for millions of babies. By bringing new technologies and new tests to the healthcare community, Baebies is providing hope to parents and a better life to newborns. Baebies is headquartered in Durham, NC. For more information, please visit www.baebies.com.
919 328 8332
Contact via Email
Read the full story here: http://www.pr.com/press-release/677870
Press Release Distributed by PR.com
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.